Enhancing antitumor efficacy of oncolytic virus M1 via albendazole-sustained CD8+ T cell activation.
Bai W, Tang X, Xiao T, Qiao Y, Tian X, Zhu B, Chen J, Chen C, Li Y, Lin X, Cai J, Lin Y, Zhu W, Yan G, Liang J, Hu J.
Bai W, et al. Among authors: li y.
Mol Ther Oncol. 2024 May 6;32(2):200813. doi: 10.1016/j.omton.2024.200813. eCollection 2024 Jun 20.
Mol Ther Oncol. 2024.
PMID: 38817541
Free PMC article.